Netflix delivered 29.5% operating margin in 2025 and guides to 31.5% for 2026. Ad revenue is expected to roughly double to $3B. The DOJ expanded its Netflix antitrust probe beyond merger review to ...

President Trump says tariffs have strengthened the economy, but GDP growth was actually below average during the first nine months of 2025. The S&P 500's forward price-to-earnings ratio is above 22, ...

The Lorain Public Library System is holding a food drive to stock the shelf of the Freedge — free outdoor refrigerator — at the South Lorain Branch. “The Freedge is a way for us to offer assistance 24 ...

Financial data-provider stocks dropped after artificial-intelligence company Anthropic announced it added new functions for legal users of its Cowork assistant. While shares of European legal ...

After a share-price collapse, UnitedHealth (UNH) has an extremely low price-to-sales ratio of 0.58x. UnitedHealth’s full-year 2025 revenue grew by a respectable 12% year over year. News of the ...

Add Yahoo as a preferred source to see more of our stories on Google. A masked U.S. Immigration and Customs Enforcement agent knocks on a car window in Minnesota on Jan. 12. A new court ruling allows ...

Earnings announcements are one of the few scheduled events that consistently move markets. Prices react not just to the reported numbers, but to how those numbers compare with expectations. A small ...

Fluence Energy is rated BUY for high-risk-tolerant investors, driven by its leadership in Battery Energy Storage Systems and a robust $5.3B backlog. FLNC's modular Smartstack BESS offers 20–25% higher ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...

An ambitious data-center project in Utah is going to need about one-quarter of the power the entire state currently uses. David Gray, co-chief executive for the project’s developer, knows he can’t get ...

Altimmune (ALT) recently released pemvidutide's 48-week topline results from their IMPACT Phase IIb trial, which revealed the drug's ability to continue improvement for several non-invasive fibrosis ...

Oracle (ORCL) stock fell more than 5% Wednesday after the Financial Times reported that private lender Blue Owl Capital (OWL) will not back a $10 billion deal for its next data center as the software ...